Study on the intervention of virtual reality technology in perioperative period of cardiac intervention patients

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039303

Enrollment

Unknown

Registered

2020-10-22

Start date

2020-11-01

Completion date

Unknown

Last updated

2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

experimental group:Wear VR glasses

control group:no VR glasses

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria of this study were as follows 1. Patients admitted for interventional therapy from September 2019 to December 2021; 2. Patients aged between 40 and 80 years old; 3. Patients who are willing to accept virtual reality diagnosis and treatment after being introduced by doctors and nurses;

Exclusion criteria

Exclusion criteria: 1. Patients with cardiogenic shock, malignant arrhythmia and other critical conditions or even life-threatening; 2. Patients with previous psychiatric history; 3. Patients with hearing or visual impairment; 4. Patients with disturbance of consciousness. It will not belong to the scope of this study.

Design outcomes

Primary

Measure	Time frame
catecholamine;	—

Countries

China

Contacts

Public ContactShuwei Huang

The Second Affiliated Hospital of Zhejiang University of traditional Chinese Medicine

hsw1104@163.com+86 13957121104

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026